Sales dont actually really have to increase that much. Were a bio company predominantly that sells oils.
once we announce that the osa phase 2b clinical trial has begun and patients have been recruited to begin the psychadelics phase 2b human trial i think that will be enough to push it towards 40cents.
add into the mix dr sud agarwal excersicing his options which adds another $40 mill to the existing $12mill cash on hand.
another anouncement regarding the second clinical psychadelics trial aswell which could be at any time.
too hard to predict with any certainty what price we will be at in the next 6 months but im almost positive it will be higher than our current level.
IHL Price at posting:
26.0¢ Sentiment: Buy Disclosure: Held